Acrivon Therapeutics, Inc. — 10-Q Filings
10 10-Q filings on record
This page lists all 10-Q filings submitted to the SEC by Acrivon Therapeutics, Inc. (ACRV), sorted by most recent first. Each row links to the full filing on EdgarLookup. Acrivon Therapeutics, Inc. has filed 10 10-Q documents with the SEC since 2021. To view all SEC filings by Acrivon Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
3
3/A
4
424B4
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 10-Q | 0001193125-25-280215 | Nov 13, 2025 | Sep 30, 2025 |
| 10-Q | 10-Q | 0000950170-25-108054 | Aug 13, 2025 | Jun 30, 2025 |
| 10-Q | 10-Q | 0000950170-25-071427 | May 14, 2025 | Mar 31, 2025 |
| 10-Q | 10-Q | 0000950170-24-125929 | Nov 13, 2024 | Sep 30, 2024 |
| 10-Q | 10-Q | 0000950170-24-095760 | Aug 13, 2024 | Jun 30, 2024 |
| 10-Q | 10-Q | 0000950170-24-059084 | May 14, 2024 | Mar 31, 2024 |
| 10-Q | 10-Q | 0000950170-23-061553 | Nov 9, 2023 | Sep 30, 2023 |
| 10-Q | 10-Q | 0000950170-23-041593 | Aug 11, 2023 | Jun 30, 2023 |
| 10-Q | 10-Q | 0000950170-23-019157 | May 9, 2023 | Mar 31, 2023 |
| 10-Q | 10-Q | 0000950170-22-026622 | Dec 15, 2022 | Sep 30, 2022 |